KEWALRAMANI RESHMA (CEO & President) reported 1 transaction at VERTEX PHARMACEUTICALS INC / MA
Review the transaction codes below to understand the nature of each event.
Filed: 2/26/2026ACC: 0000875320-26-000114
DirectorOfficer· CEO & President
Since Feb 2026
-4.98K
Net shares
Net seller
$2.42M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.98K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.98K
Price / share
$485.11
Trade value
$2.42M
% of position
3.5%
2/24/2026
143.26K→138.28K
Total
Net shares
−4.98K
Net value
-$2.42M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | F · Tax Withholding | −4.98K | $485.11 | $2.42M | 3.5% | 143.26K | 138.28K |
| Total | −4.98K | -$2.42M | ||||||
Derivative Transactions0
No derivative transactions reported